Please wait...
GulfBase Live Support
- Lebanon receives preliminary approval to increase World Bank loan to $400m
- China Exempts Some Goods from US Tariffs to Limit trade War Pain
- Saudi Arabia completes 674 Vision 2030 initiatives, achieves 93% of KPIs as 9th year milestone marked
- Foreign investors remain net buyers of GCC stock market in first quarter
- Quarterly earnings announcement, tariff hold supports QSE index rise
- Gold prices drop more than 1%
- Saudi Arabia's Vision 2030 enters final phase with strong momentum
- Saudi Arabia takes part in European Economic Congress
- UAE jobs: Etihad Airways to hold career fair for Emiratis on May 22
- Adnoc Distribution to operate 500 high-power EV chargers by 2028
- AVALONPHARMA
- :129.4
- :127.4
- ('000):20,000
- ( '000):2,580,000
- :0
-
16,554 - :0
- :
- 17.31%
- 20.56%
-
364 -
():
2,131,485.8 - ():6,379,965
- :0.33
- Performance Comparison
- :Saudi Stock Exchange
- :Pharma, Biotech & Life Science
- :Small Cap
- :Health Care
Company Overview
- :29/06/1998
- :SAR 200,000,000
- :SAR 10
Activities
Middle East Pharmaceutical Industries Company is a prominent pharmaceutical company headquartered in Riyadh, Saudi Arabia. The company focuses on research, development, manufacturing, and marketing of generic medicines and pharmaceutical preparations. Their product portfolio includes treatments for various health conditions, such as: skin diseases, respiratory, central nervous, digestive, and musculoskeletal system disorders, urinary and reproductive system issues, diabetes, cardiovascular diseases, and anti-infective treatments, pain relief, antiseptics, and men's and women's health products. The company operates through three segments: Private, Public, and Export. Additionally, they offer contract manufacturing services and specialize in cosmetic, health products, and nutritional supplements. Formerly known as Middle East Chemical Products Factory Company, it changed its name to Middle East Pharmaceutical Industries Company in January 2006. The company also exports its products internationally, contributing to healthcare access beyond its home country.
-
Chairman:Ahmed S. A. Al-Tabbaa
-
Vice-chairman:Hisham M. M. Attar
-
CEO:Mohamed M. M. Al-Ghannam
-
General Manager:
-
Managing Director:
-
Board Members:
Faisal S. M. Al-Jaman
Mohammed M. Al-Ghannam
Omar M. S. Al-Jaroudi
-
Auditors:
KPMG Professional Consulting
CFO
| Announced On | Period | As Of | Net Profit (SAR Mil) | Growth (%) |
|---|---|---|---|---|
| 23/03/2025 | 12-Month | 31/12/2024 | 80 | 21.3 |
| 07/11/2024 | 9-Month | 30/09/2024 | 35 | 0 |
| 06/08/2024 | 6-Month | 30/06/2024 | 31 | 77.63 |
| 19/05/2024 | 3-Month | 31/03/2024 | 09 | 0 |
| 25/03/2024 | 12-Month | 30/09/2023 | 66 | 10.73 |
- investor.relations@avalon.com.sa
- www.avalonpharmaceutical.com
- P.O. Box 3800 Riyadh 14331
| Market Cap US$ Mil |
Last Price Local Cry |
Price Change (%) 1 Day |
Price Change (%) 1 Year |
P/E TTM | P/B MRQ | Dividend Yield (%) | Beta | ROA (%) | ROE (%) | |
|---|---|---|---|---|---|---|---|---|---|---|
| SULAIMANALHABIB | 26,452.79 | 285.2 | 0.56 | -2.58 | 44.58 | 0 | 0 | 0 | 0 | 0 |
| PUREHEALTH | 8,468.44 | 2.9 | 3.57 | 0 | 27.7 | 0 | 0 | 0 | 0 | 0 |
| ARMAH | 7,758.66 | 88 | -0.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NAHDI | 3,949.53 | 114.6 | 0.52 | -15.6 | 17.78 | 0 | 0 | 0 | 0 | 0 |
| MOUWASAT | 3,944.2 | 73.9 | -0.14 | -28.46 | 22.49 | 2.66 | 0 | 0.81 | 13.85 | 22.49 |
| DALLAHHEALTH | 3,269.62 | 124.2 | -1.12 | -5.63 | 26.05 | 4.56 | 0 | 0.93 | 12.1 | 17.53 |
| FAKEEHCARE | 2,819.36 | 45.9 | 0.65 | 0 | 39.29 | 0 | 0 | 0 | 0 | 0 |
| JAMJOOMPHARMA | 2,801.98 | 150.6 | 0.26 | 18.09 | 30.09 | 0 | 0 | 0 | 0 | 0 |
| AME | 2,249.79 | 120.4 | -0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NABAALSAHA | 1,858.04 | 68.6 | 3.31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CARE | 1,754.63 | 148.2 | 0.95 | -16.19 | 23.99 | 6.82 | 0 | 0.85 | -0.59 | -0.89 |
| TIBBIYAH | 1,732.25 | 33.35 | 2.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SAUDIGERMANHEALTH | 1,587 | 64.9 | 0.3 | -28.25 | 28.17 | 3.65 | 0 | 0.79 | 11.92 | 18.76 |
| PROMEDEX | 930.88 | 99.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SPIMACO | 786.71 | 24.9 | 1.21 | -2.21 | 72.91 | 1.12 | 0 | 0.91 | 8.47 | 15.11 |
| ALMUJTAMAMEDICAL | 770.92 | 30 | -1.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| AVALONPHARMA | 682.24 | 129 | 0.78 | 0 | 31.82 | 0 | 0 | 0 | 0 | 0 |
| MIRAL | 626.81 | 117.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QOMEL | 545.66 | 58 | -0.86 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| MIDAN | 529.53 | 797 | 0 | -4.78 | 13.35 | 1.39 | 0 | 0 | 12.06 | 17.87 |
| JULPHAR | 449.67 | 1.43 | 0 | 0 | -71.86 | 0.69 | 5.27 | 0.2 | 4.09 | 0 |
| AYYAN | 413.02 | 15.6 | 1.29 | -8.1 | -7.36 | 1.55 | 0 | 0.81 | -2 | -2.64 |
| GMPC | 367.17 | 1.98 | 2.59 | 0 | 0 | 1.03 | 3 | -0.08 | 75.81 | 111.42 |
| MCGS | 355.59 | 4.62 | -0.44 | -0.04 | 21.74 | 0.13 | 5.86 | 0.98 | 6.76 | 7.99 |
| ATC.KW | 355.33 | 722 | 0 | 0 | 39.74 | 2.19 | 1.82 | -0.01 | 2.93 | 12.88 |
| EQUIPMENTHOUSE | 321.4 | 41.25 | 2.61 | 5.1 | 25.08 | 0 | 0 | 0 | 0 | 0 |
| LANA | 287.82 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| TMC | 229.62 | 21.5 | -0.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BURJEEL | 223.86 | 1.56 | -1.27 | 0 | 1.76 | 0 | 0 | 0 | 0 | 0 |
| RPM | 216.67 | 3.96 | -0.51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CMCER | 126 | 6.24 | 1.62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALMODAWAT | 111.65 | 16.84 | -4.54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| FUTURECARE | 83.95 | 6.34 | 0.63 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| QGMD | 42.46 | 1.35 | 0 | 16.69 | -2.28 | 0.23 | 0 | 0.76 | -6.18 | 0 |
| SMILECARE | 31.18 | 5.7 | -2.57 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| BALSMMEDICAL | 24.98 | 75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ALRAZI | 18.17 | 45 | 0.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| JANA | 15.33 | 19 | 6.14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financial Information Co.
P.O. Box 69410, Jeddah 11547, Saudi Arabia